Chong Yang
Impact in
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 5
-
- Parasitic infections in humans and animals 8
- Co-authors
- Heshui Wu (15 shared papers)Xin Jin (11 shared papers)Ping Fan (7 shared papers)Wenke Cheng (2 shared papers)Zhen Zhang (1 shared paper)Weijun Liu (1 shared paper)Shikai Zhu (11 shared papers)Hongji Yang (14 shared papers)
- Journals
- PLoS ONE (4 papers)Journal of the American College of Surgeons (3 papers)Cell Death and Disease (2 papers)Pancreas (2 papers)Medicine (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chong Yang
62 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 113
- Biochemistry 67
- Oncology 257
- Cancer Research 137
- Pathology and Forensic Medicine 88
- Immunology 106
Countries citing papers authored by Chong Yang
This map shows the geographic impact of Chong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Yang more than expected).
Fields of papers citing papers by Chong Yang
This network shows the impact of papers produced by Chong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Yang. The network helps show where Chong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 165 | |
| 2 | 2016 | 102 | |
| 3 | 2003 | 97 | |
| 4 | 2017 | 88 | |
| 5 | 2018 | 60 | |
| 6 | 2023 | 49 | |
| 7 | 2017 | 41 | |
| 8 | 2021 | 40 | |
| 9 | 2016 | 39 | |
| 10 | 2015 | 36 | |
| 11 | USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1. | 2019 | 36 |
| 12 | 2014 | 35 | |
| 13 | 2015 | 28 | |
| 14 | 2019 | 27 | |
| 15 | 2021 | 23 | |
| 16 | 2016 | 20 | |
| 17 | 2019 | 20 | |
| 18 | 2024 | 20 | |
| 19 | 2020 | 19 | |
| 20 | 2023 | 17 |
About Chong Yang
Chong Yang is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Surgery and Molecular Biology, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (8 papers), Parasitic infections in humans and animals (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer-related molecular mechanisms research (5 papers), Congenital Anomalies and Fetal Surgery (4 papers), RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (3 papers) and Amoebic Infections and Treatments (3 papers). The work is most often cited by research in Biochemistry (67 citations), Oncology (257 citations), Cancer Research (137 citations), Pathology and Forensic Medicine (88 citations) and Immunology (106 citations). Chong Yang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Heshui Wu, Xin Jin, Ping Fan, Wenke Cheng, Zhen Zhang, Weijun Liu, Shikai Zhu, Hongji Yang, Chao Lian Xie and Yueming Jiang. Their work appears in journals such as PLoS ONE, Journal of the American College of Surgeons, Cell Death and Disease, Pancreas and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.